Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes

Osteoprotegerin Predicts Long-Term Outcome in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention

(2012) Sune Pedersen et al.   CARDIOLOGY

Prevalence and progression of peripheral vascular calcification in type 2 diabetes subjects with preserved kidney function

(2012) Dhruv K. Singh et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria

(2011) Henrik Reinhard et al.   Cardiovascular Diabetology

Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men

(2011) Weena JY Chen et al.   Cardiovascular Diabetology

Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus

(2011) Mikael K Poulsen et al.   Cardiovascular Diabetology

Estrogen Inhibits Vascular Calcification via Vascular RANKL System

(2010) Mariana Kiomy Osako et al.   CIRCULATION RESEARCH

The bone–vascular axis in chronic kidney disease

(2010) Linda Demer et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Osteogenic induction and 1,25-dihydroxyvitamin D3 oppositely regulate the proliferation and expression of RANKL and the vitamin D receptor of human periodontal ligament cells

(2009) Xiaolin Tang et al.   ARCHIVES OF ORAL BIOLOGY

Plaque characterization of non-culprit lesions by virtual histology intravascular ultrasound in diabetic patients: Impact of renal function

(2009) Manabu Ogita et al.   Journal of Cardiology

Relationship between circulating FGF23 and total body atherosclerosis in the community

(2009) Majd A. I. Mirza et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Osteoprotegerin Inhibits Vascular Calcification Without Affecting Atherosclerosis in ldlr (−/−) Mice

(2008) Sean Morony et al.   CIRCULATION